Both agonists affect cancer in vitro by decreasing the proliferation and metabolic pathways at varying concentrations
[2] Liu X, Zhang Y, Zheng SY, et al
More serious but less common risks include pancreatitis, gallbladder disease, acute kidney injury (often secondary to dehydration from gastrointestinal effects), and hypoglycaemia when used with insulin or sulphonylureas
Arnold, E
In the main trial (SURMOUNT-1) of 2,539 participants, adults with obesity or being overweight achieved up to 22.5% average weight loss over 72 weeks on the highest dose of tirzepatide, with lower doses also delivering substantial results
At Genesis Lifestyle Medicine, we offer GLP-1 therapy in Hendersonville as part of a customized plan designed to support your progress without relying on willpower alone